SMMT
Summit Therapeutics·NASDAQ
--
--(--)
--
--(--)
7.83 / 10
Outperform
Sentiment is Outperform (7.83) and fund‑flow score 7.86, reflecting strong capital inflows despite a negative overall trend. Small‑cap inflow is positive, larger blocks are negative. Analysts are split: 1 Strong Buy, 1 Neutral, weighted rating 7.81, showing cautious optimism.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-03-16
InstitutionJefferies
Times predicted1
Historical Win Rate100.0%
Is money flowing into or out of SMMT?
- SMMT holds a Bullish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 7.83/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
